In summary, TGF-β signalling displays anti-proliferative and tumour suppressive functions during early tumourigenesis, but tumour cells often become refractory to TGF-β-mediated growth inhibition as cancer progresses. This evidence concerns the gene TGFB1 and neoplasm.